Exousia Bio (LMMY) Invested Capital (2022 - 2025)
Lamy (LMMY) has disclosed Invested Capital for 4 consecutive years, with $21.8 million as the latest value for Q4 2025.
- Quarterly Invested Capital rose 87570.58% to $21.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.8 million through Nov 2025, up 87570.58% year-over-year, with the annual reading at -$54895.0 for FY2024, 88.72% down from the prior year.
- Invested Capital hit $21.8 million in Q4 2025 for Lamy, up from -$35314.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $21.8 million in Q4 2025 to a low of -$58805.0 in Q3 2024.
- Historically, Invested Capital has averaged $1.8 million across 4 years, with a median of -$32201.0 in 2023.
- Biggest five-year swings in Invested Capital: crashed 207.64% in 2023 and later soared 87570.58% in 2025.
- Year by year, Invested Capital stood at -$21814.0 in 2022, then crashed by 105.47% to -$44822.0 in 2023, then soared by 155.45% to $24854.0 in 2024, then skyrocketed by 87570.58% to $21.8 million in 2025.
- Business Quant data shows Invested Capital for LMMY at $21.8 million in Q4 2025, -$35314.0 in Q3 2025, and $24854.0 in Q4 2024.